Scarica l'app Stockscreener
5.05
2.70%
-0.14
Dopo l'orario di chiusura:
5.06
0.010
+0.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.19
Aprire:
$5.14
Volume 24 ore:
257.85K
Relative Volume:
0.87
Capitalizzazione di mercato:
$323.50M
Reddito:
-
Utile/perdita netta:
$-45.08M
Rapporto P/E:
-6.9178
EPS:
-0.73
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
+6.32%
1M Prestazione:
+14.51%
6M Prestazione:
+268.61%
1 anno Prestazione:
+92.02%
Intervallo 1D:
$4.96
$5.24
Intervallo di 1 settimana:
$4.56
$5.35
Portata 52W:
$0.726
$6.55
Galectin Therapeutics Inc Stock (GALT) Company Profile
Nome
Galectin Therapeutics Inc
Settore
Industria
Telefono
678-620-3186
Indirizzo
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Confronta GALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
5.05 | 317.74M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-13 | Iniziato | B. Riley FBR | Buy |
| 2017-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-19 | Iniziato | ROTH Capital | Buy |
| 2017-03-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Downgrade | ROTH Capital | Buy → Sell |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-09-21 | Iniziato | H.C. Wainwright | Buy |
| 2014-08-01 | Downgrade | Aegis Capital | Buy → Hold |
| 2014-07-30 | Reiterato | MLV & Co | Buy |
| 2014-07-29 | Reiterato | MLV & Co | Buy |
| 2014-04-02 | Reiterato | MLV & Co | Buy |
| 2014-02-10 | Reiterato | Aegis Capital | Buy |
| 2014-01-09 | Reiterato | Aegis Capital | Buy |
| 2013-12-03 | Iniziato | MLV & Co | Buy |
| 2013-08-19 | Reiterato | Aegis Capital | Buy |
Mostra tutto
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
Short interest data insights for Galectin Therapeutics Inc.Weekly Trade Report & Technical Confirmation Trade Alerts - newser.com
Identifying reversal signals in Galectin Therapeutics Inc.Share Buyback & Free Verified High Yield Trade Plans - newser.com
Trend analysis for Galectin Therapeutics Inc. this weekCEO Change & Accurate Intraday Trade Tips - newser.com
Galectin Therapeutics Inc.'s (NASDAQ:GALT) market cap up US$42m last week, benefiting both individual investors who own 53% as well as insiders - simplywall.st
Can machine learning forecast Galectin Therapeutics Inc. recoveryJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
Galectin Therapeutics Inc Stock Analysis and ForecastMarket Depth Overview & Big Profit Low Trading - earlytimes.in
Galectin Therapeutics' (GALT) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Galectin Therapeutics’ (GALT) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
Should Dividend Investors Consider Omnipotent Industries Limited in YEAREconomic Data Impact & Free Dashboard to Track Market Momentum - earlytimes.in
Is Galectin Therapeutics Inc a good long term investmentChart Pattern Recognition & Connect With Bulls, Avoid the Bears - earlytimes.in
Prevents Varices at 18 Months — Galectin Therapeutics to Present NAVIGATE Data at AASLD Nov 10 - Stock Titan
Will Galectin Therapeutics Inc. (PHPN) stock hit Wall Street targetsJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
How sentiment analysis helps forecast Galectin Therapeutics Inc.July 2025 Decliners & Verified Short-Term Plans - newser.com
Market reaction to Galectin Therapeutics Inc.’s recent newsQuarterly Market Review & Fast Gain Stock Trading Tips - newser.com
Is Galectin Therapeutics Inc. (PHPN) stock cheap by valuation metricsPortfolio Update Summary & Weekly Breakout Opportunity Watchlist - newser.com
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesJuly 2025 Summary & Daily Price Action Insights - newser.com
Analyzing Galectin Therapeutics Inc. with risk reward ratio charts2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Using R and stats models for Galectin Therapeutics Inc. forecastingWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com
Chart overlay techniques for tracking Galectin Therapeutics Inc.July 2025 Recap & Precise Swing Trade Alerts - newser.com
What drives Galectin Therapeutics Inc PHPN stock pricePrice Momentum Alerts & High Yield Market Growth - earlytimes.in
Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Galectin Therapeutics Inc Azioni (GALT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| CALLICUTT JACK W | Chief Financial Officer |
Sep 12 '25 |
Sale |
6.44 |
8,706 |
56,054 |
7,614 |
| LEWIS JOEL | President and CEO |
Sep 12 '25 |
Option Exercise |
2.39 |
14,000 |
33,460 |
846,592 |
| LEWIS JOEL | President and CEO |
Sep 12 '25 |
Sale |
6.36 |
14,000 |
89,048 |
832,592 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):